These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24960985)

  • 1. Multidisciplinary team care for CKD-MBD. Achieving KDIGO guideline recommendations in the bundling era.
    McCann L; Hoefs M
    Nephrol News Issues; 2014 Apr; 28(4):24-6, 28, 30-2 passim. PubMed ID: 24960985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
    Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
    Yusuf AA; Howell BL; Powers CA; St Peter WL
    Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing Financial Disincentives to Improve CKD Care.
    Berns JS; Saffer TL; Lin E
    J Am Soc Nephrol; 2018 Nov; 29(11):2610-2612. PubMed ID: 30305309
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
    Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
    Djukanović L; Dimković N; Marinković J; Djurić Ž; Knežević V; Lazarević T; Ljubenović S; Marković R; Rabrenović V
    Nephron; 2016; 132(3):168-74. PubMed ID: 26914677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
    Stevens PE; Levin A;
    Ann Intern Med; 2013 Jun; 158(11):825-30. PubMed ID: 23732715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
    Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
    Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; end-stage renal disease quality incentive program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Nov; 77(218):67450-531. PubMed ID: 23139948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.
    Toussaint ND; Pedagogos E; Beavis J; Becker GJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2011 Apr; 26(4):1319-26. PubMed ID: 20935019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
    Kliger AS; Foley RN; Goldfarb DS; Goldstein SL; Johansen K; Singh A; Szczech L
    Am J Kidney Dis; 2013 Nov; 62(5):849-59. PubMed ID: 23891356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm?
    Weiner DE; Winkelmayer WC
    Am J Kidney Dis; 2014 May; 63(5):854-8. PubMed ID: 24725918
    [No Abstract]   [Full Text] [Related]  

  • 19. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
    Moist LM; Troyanov S; White CT; Wazny LD; Wilson JA; McFarlane P; Harwood L; Sood MM; Soroka SD; Bass A; Manns BJ
    Am J Kidney Dis; 2013 Nov; 62(5):860-73. PubMed ID: 24054466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.